Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CASTLE BIOSCIENCES INC Director's Dealing 2021

Nov 18, 2021

32601_dirs_2021-11-17_cf2b6a45-7f78-429c-ba28-65f7b1272f02.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-11-15

Reporting Person: MAETZOLD DEREK J (Director, Pres. & Chief Exec. Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-15 Common Stock M 16406 $2.36 Acquired 302424 Direct
2021-11-15 Common Stock S 15394 $52.474 Disposed 287030 Direct
2021-11-15 Common Stock S 1012 $53.042 Disposed 286018 Direct
2021-11-16 Common Stock M 15409 $3.72 Acquired 301427 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-11-15 Stock option (right to buy) $2.36 M 16406 Disposed 2022-07-20 Common Stock (16406.0) Direct
2021-11-16 Stock option (right to buy) $3.72 M 15409 Disposed 2024-03-26 Common Stock (15409.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 150567 Indirect
Common Stock 127728 Indirect
Common Stock 137965 Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $52.000 to $52.995, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This transaction was executed in multiple trades at prices ranging from $53.000 to $53.170, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.

F4: Held by DJM Grantor Retained Annuity Trust No. 1 of which the Reporting Person is the trustee and beneficiary.

F5: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.

F6: The shares subject to the option are fully vested.